Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties

Int J Cardiol. 2015 Feb 15:181:443-5. doi: 10.1016/j.ijcard.2014.11.131. Epub 2014 Nov 25.

Authors

Stefano De Servi¹, Claudio Cavallini², Sergio Leonardi³, Marco Ferlini³

Affiliations

¹ Coronary Care and Cardiology Unit, IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: http://www.s.deservi#smatteo.pv.it.
² Cardiology Unit, Azienda Ospedaliero-Universitaria, Perugia, Italy.
³ Coronary Care and Cardiology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 25590784
DOI: 10.1016/j.ijcard.2014.11.131

No abstract available

Keywords: Acute coronary syndromes; Antiplatelet agents; Prasugrel; Ticagrelor.

Publication types

Comparative Study
Letter
Randomized Controlled Trial

MeSH terms

Acute Coronary Syndrome / diagnosis
Acute Coronary Syndrome / drug therapy*
Acute Coronary Syndrome / surgery*
Adenosine / analogs & derivatives*
Adenosine / therapeutic use
Aged
Clopidogrel
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Prasugrel Hydrochloride / therapeutic use*
Ticagrelor
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Prasugrel Hydrochloride
Ticagrelor
Adenosine
Ticlopidine